Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

The drug is used to treat psychotic disorders such as schizophrenia

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 04:01 PM IST
article-image
Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet | Image: Ajanta Pharma (Representative)

Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.

The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.

The drug is used to treat psychotic disorders such as schizophrenia.

RECENT STORIES

Reliance Jio Network Down In Mumbai And Other Cities, Users Report No Signal

Reliance Jio Network Down In Mumbai And Other Cities, Users Report No Signal

Adani Enterprises Announces ₹1,000 Crore NCD Issue Offering Up To 9.3%

Adani Enterprises Announces ₹1,000 Crore NCD Issue Offering Up To 9.3%

Gaja Capital Plans IPO, Files Draft Papers With Sebi

Gaja Capital Plans IPO, Files Draft Papers With Sebi

At BRICS Meet, FM Nirmala Sitharaman Holds Bilateral Talks With China, Russia, Brazil, And Indonesia

At BRICS Meet, FM Nirmala Sitharaman Holds Bilateral Talks With China, Russia, Brazil, And Indonesia

New Aadhaar Rules Announced, Check Updated Document List For Enrolment & Changes

New Aadhaar Rules Announced, Check Updated Document List For Enrolment & Changes